AU2806692A - Medicament for the treatment of anxiety - Google Patents

Medicament for the treatment of anxiety

Info

Publication number
AU2806692A
AU2806692A AU28066/92A AU2806692A AU2806692A AU 2806692 A AU2806692 A AU 2806692A AU 28066/92 A AU28066/92 A AU 28066/92A AU 2806692 A AU2806692 A AU 2806692A AU 2806692 A AU2806692 A AU 2806692A
Authority
AU
Australia
Prior art keywords
anxiety
medicament
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28066/92A
Inventor
Joseph Weinstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2806692A publication Critical patent/AU2806692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU28066/92A 1991-10-10 1992-10-09 Medicament for the treatment of anxiety Abandoned AU2806692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9121463 1991-10-10
GB919121463A GB9121463D0 (en) 1991-10-10 1991-10-10 Medicament

Publications (1)

Publication Number Publication Date
AU2806692A true AU2806692A (en) 1993-05-03

Family

ID=10702666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28066/92A Abandoned AU2806692A (en) 1991-10-10 1992-10-09 Medicament for the treatment of anxiety

Country Status (3)

Country Link
AU (1) AU2806692A (en)
GB (1) GB9121463D0 (en)
WO (1) WO1993006828A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213934D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Chemical compounds
IT1255461B (en) * 1992-07-28 1995-11-02 Luso Farmaco Inst ETHERS OF IMIDAZOLI ACTIVATED IN II ANTAGONIST
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
RS52931B (en) 2004-02-20 2014-02-28 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (en) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (en) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 Ultra-pure agonists of guanylate cyclase C, methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931430A (en) * 1987-12-14 1990-06-05 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ACE inhibitor
DK0403159T3 (en) * 1989-06-14 2000-08-14 Smithkline Beecham Corp imidazolyl
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
CA2057089A1 (en) * 1990-12-07 1992-06-08 Eric E. Allen Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
US5157040A (en) * 1991-04-05 1992-10-20 Merck & Co., Inc. Substituted quinolines as angiotensin ii antagonists
US5151435A (en) * 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole

Also Published As

Publication number Publication date
WO1993006828A1 (en) 1993-04-15
GB9121463D0 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
AU7545594A (en) Implantable device for the treatment of aedemas
AU5016593A (en) Apparatus for the diagnosis of sleep apnea
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
AU1532492A (en) Use of heterocyclic compounds for the treatment of inflammatory pain
AU4048295A (en) Peptide medicaments for the treatment of disease
AU618231B3 (en) Treatment of emulsions
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
AU2806692A (en) Medicament for the treatment of anxiety
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
GB9103278D0 (en) Drug for the treatment of dermatitis
AU4081393A (en) Medicaments for the treatment of anxiety
ZA929879B (en) Compositions for the treatment of mammalian diseases.
ZA932450B (en) Drugs for the treatment of diabetes
AU3279993A (en) A device for the treatment/purification of sewage-effluent
GB9217124D0 (en) Medical treatment
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
AU2875092A (en) Methods for the treatment of hyperlipidemia using azaspiranes
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines
AU1500092A (en) Use of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety